Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GPR37L1 Biologics Sequence Review Report 2026: G protein-coupled receptor 37-like 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR37L1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FGF1 Biologics Sequence Review Report 2026: Fibroblast growth factor 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGA10 Biologics Sequence Review Report 2026: Integrin alpha-10 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGA10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR39 Biologics Sequence Review Report 2026: G protein-coupled receptor 39 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR39 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR42 Biologics Sequence Review Report 2026: G protein-coupled receptor 42 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR42 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLDN3 Biologics Sequence Review Report 2026: Claudin-3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CLDN3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TLR4 Biologics Sequence Review Report 2026: Toll-like receptor 4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TLR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL1B Biologics Sequence Review Report 2026: Interleukin-1 beta Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL1A Biologics Sequence Review Report 2026: Interleukin-1 alpha Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL1A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL18BP Biologics Sequence Review Report 2026: Interleukin-18-binding protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL18BP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
FGF19 Biologics Sequence Review Report 2026: Fibroblast growth factor 19 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXCL14 Biologics Sequence Review Report 2026: C-X-C motif chemokine 14 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCL14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
598
599
600
601
602
>>
1905
>